What the Evidence Really Says About Cannabis for Spinal Stenosis Pain

By Dr. Miller Published Updated
Cannabis leaf with a stylized graphic novel rendering

Spinal stenosis occurs when the spaces within the spine narrow and place pressure on the spinal cord or nearby nerve roots. The condition most often affects the lower back or neck, causing symptoms such as back or neck pain, burning or radiating pain, numbness, tingling, cramping, and weakness in the legs, feet, arms, or hands. The National Institute of Arthritis and Musculoskeletal and Skin Diseases notes that common causes include age-related changes, osteoarthritis, bone spurs, thickened ligaments, herniated disks, and congenital narrowing.

Cannabis and cannabis-derived medicines have been studied as possible treatments for some types of chronic pain. However, the evidence does not show that cannabis reverses spinal narrowing, relieves pressure on the spinal cord, or treats the underlying cause of spinal stenosis. At most, it may provide modest symptom relief for some adults, particularly those with neuropathic pain.

What research has found

A 2020 systematic review and meta-analysis published in Cannabis and Cannabinoid Research examined six randomized controlled trials involving 678 people with acute pain. Overall, cannabinoids produced a small reduction in pain compared with placebo. The apparent benefit from intramuscular treatment came from a single trial involving 56 participants who received the synthetic cannabinoid levonantradol. The review did not establish that cannabis reduced acute pain by 95%, as the original article claimed, and its authors rated the overall evidence as low quality.

That finding also has limited relevance to spinal stenosis. The trial involved acute pain rather than pain caused by chronic spinal nerve compression, and the treatment was an injectable synthetic cannabinoid—not medical marijuana used at home. The results should therefore not be interpreted as evidence that cannabis injections or other cannabis products are an established treatment for spinal stenosis.

Evidence for chronic pain is somewhat more applicable but remains limited. The Agency for Healthcare Research and Quality’s living systematic review found that some high-THC or balanced THC-CBD products may produce small short-term improvements in pain, mainly in studies of adults with neuropathic pain. The review also found frequent adverse effects, including dizziness, sedation, and nausea. Evidence for CBD alone, topical products, long-term treatment, and whole-plant cannabis was sparse or insufficient.

THC, CBD, and nerve-related pain

THC is the cannabinoid primarily responsible for cannabis’s intoxicating effects. CBD is not generally intoxicating, but it can still affect the body and interact with medications. Both compounds act on biological signaling systems involved in pain processing, but laboratory mechanisms do not necessarily translate into meaningful benefits for people with spinal stenosis.

Some people with spinal stenosis experience nerve-related pain that travels into the arms or legs. Research on cannabis-based medicines for neuropathic pain suggests that certain THC-containing products may help a subset of patients achieve a small reduction in pain. That evidence comes from conditions such as multiple sclerosis, diabetic neuropathy, spinal cord injury, and other nerve disorders—not specifically from large clinical trials in people with spinal stenosis.

Claims that topical CBD reliably treats sciatica or stenosis-related nerve pain are also premature. Topical products have been studied far less than oral or oromucosal preparations, and their absorption, dose, product quality, and effectiveness can vary considerably.

Safety and treatment decisions

Cannabis may cause drowsiness, impaired coordination, dizziness, anxiety, changes in alertness, and cognitive effects. These risks can be especially important for older adults, people at risk of falling, and anyone taking sedatives, opioids, sleep medicines, or other drugs that affect the nervous system. CBD may also alter the effects of other medicines, and the U.S. Food and Drug Administration warns about potential drug interactions and other risks associated with CBD products.

People who are pregnant, planning to become pregnant, or breastfeeding should avoid cannabis unless specifically advised otherwise by a qualified clinician. The Centers for Disease Control and Prevention advises against cannabis use during pregnancy and breastfeeding because THC can reach the developing fetus and may be passed to an infant through breast milk.

Anyone considering cannabis for spinal stenosis should discuss it with a physician or pharmacist before starting treatment. A clinician can review possible interactions, recommend a regulated product if appropriate, and determine whether symptoms require a different approach. Cannabis should not replace treatments prescribed for the underlying spinal condition.

Understanding the location of spinal stenosis

Lumbar spinal stenosis affects the lower back and commonly causes pain, numbness, tingling, or weakness in the buttocks, legs, and feet. Cervical spinal stenosis affects the neck and may produce symptoms in the shoulders, arms, hands, or fingers. Thoracic spinal stenosis occurs in the mid-back and is less common; it can affect the trunk or legs depending on which nerves are compressed.

Treatment depends on the location and severity of the narrowing and may include exercise or physical therapy, activity changes, non-cannabis pain medicines, injections, or surgery. Progressive weakness, difficulty walking, or new loss of bladder or bowel control requires prompt medical evaluation.

Bottom line

Cannabis-based products may offer modest short-term pain relief for some adults with chronic neuropathic pain, but there is no strong evidence that they specifically treat spinal stenosis. The strongest claims in for a reduction in acute pain and a clear benefit from topical CBD overstate what the research shows. For people with spinal stenosis, cannabis is best viewed as a possible adjunctive option to discuss with a healthcare professional, not as a proven treatment for nerve compression or spinal narrowing.

dr paul miller md

About the Author: Dr. Miller

Dr. Miller is committed to finding new and innovative ways to help his patients manage their symptoms and improve their overall quality of life. He has a particular interest in the therapeutic potential of medical cannabis and is passionate about educating both his colleagues and patients on its safe and effective use. He is also committed to continuing his education and staying up-to-date on the latest advances in neurology and cannabis research.